These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26311424)

  • 21. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
    Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
    Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
    Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA
    Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine Derivatives with Different Pharmacological Activities via Structural Modifications.
    Xiao D; Liu Z; Zhang S; Zhou M; He F; Zou M; Peng J; Xie X; Liu Y; Peng D
    Mini Rev Med Chem; 2018; 18(17):1424-1441. PubMed ID: 28325147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.
    Wang S; He B; Hang W; Wu N; Xia L; Wang X; Zhang Q; Zhou X; Feng Z; Chen Q; Chen J
    J Alzheimers Dis; 2018; 65(4):1385-1400. PubMed ID: 30175975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of berberine in Alzheimer's disease.
    Cai Z; Wang C; Yang W
    Neuropsychiatr Dis Treat; 2016; 12():2509-2520. PubMed ID: 27757035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress of berberine for treatment of type 2 diabetes].
    Deng XW; Xie N
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1374-8. PubMed ID: 25039167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine.
    Altern Med Rev; 2000 Apr; 5(2):175-7. PubMed ID: 10767672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research.
    Ye M; Fu S; Pi R; He F
    J Pharm Pharmacol; 2009 Jul; 61(7):831-7. PubMed ID: 19589224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene therapy and Alzheimer's disease].
    Li J; Li W; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 40(4):428-32. PubMed ID: 25931222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newest developments in dementia treatment and prevention.
    Miller CA
    Geriatr Nurs; 2001; 22(4):216, 218. PubMed ID: 11505251
    [No Abstract]   [Full Text] [Related]  

  • 33. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders.
    Kulkarni SK; Dhir A
    Phytother Res; 2010 Mar; 24(3):317-24. PubMed ID: 19998323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-inflammatory potential of berberine in vitro and in vivo.
    Kuo CL; Chi CW; Liu TY
    Cancer Lett; 2004 Jan; 203(2):127-37. PubMed ID: 14732220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary studies of berberine and its semi-synthetic derivatives as a promising class of multi-target anti-parkinson agents.
    Ribaudo G; Zanforlin E; Canton M; Bova S; Zagotto G
    Nat Prod Res; 2018 Jun; 32(12):1395-1401. PubMed ID: 28691859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer's Disease Target.
    Kaufmann D; Kaur Dogra A; Tahrani A; Herrmann F; Wink M
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27589716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine attenuates depressive-like behaviors by suppressing neuro-inflammation in stressed mice.
    Liu YM; Niu L; Wang LL; Bai L; Fang XY; Li YC; Yi LT
    Brain Res Bull; 2017 Sep; 134():220-227. PubMed ID: 28842306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea.
    Derosa G; Maffioli P
    Curr Top Med Chem; 2014; 14(2):200-6. PubMed ID: 24359201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms.
    Ni WJ; Ding HH; Tang LQ
    Eur J Pharmacol; 2015 Aug; 760():103-12. PubMed ID: 25912800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.